Replies to post #118644 on Biotech Values

[DewDiligence]

Teva’s damage control PR, which came out at 2pm ET, did not do much to control the damage:

http://finance.yahoo.com/news/Teva-Pharmaceutical-bw-1941617022.html?x=0&.v=1

The share price dropped another 2% after the PR hit the wires.

[DewDiligence]

Active Biotech, Teva’s Laquinimod partner, is down 36% in Stockholm on the BG-12 threat:

http://www.bloomberg.com/apps/quote?ticker=ACTI:SS

The Stockholm market was closed Thursday afternoon, Friday, and Monday for Easter and is trading for the first time since BIIB reported the BG-12 results on its CC last week.